Medical specialists from France tagged as investigators in clinical trials studying Myelodysplastic Syndromes
Total 296 results
-
Elias KFOURYSeen in:
- Meaux, Meaux CH
Trials:- NCT03643042 (Principal Investigator)
Conditions: -
Elisabeth BERGER, MDSeen in:
- Dijon, CHU Dijon
Trials:- NCT00411905 (Principal Investigator)
Conditions: -
Elsa LESTANG, MDSeen in:
- Saint-Nazaire, CH Saint Nazaire
- Saint-Nazaire, Centre Hospitalier de St Nazaire
Trials:- NCT05298293 (Principal Investigator)
- NCT03223961 (Principal Investigator)
Conditions: -
Emilie LemasleSeen in:
- Rouen, FR-Rouen cedex-BECQUEREL
Trials:- NCT04027309 (Principal Investigator)
-
Emmanuel GYAN, MDSeen in:
- Cedex 01, Tours, CHU de TOURS - Hôpital Bretonneau
- Tours, CHU Tours
- Tours, CHU de TOURS - Hôpital Bretonneau
- Tours, CHU de Tours
- Tours, Tours University Hospital
Trials:- NCT05178849 (Principal Investigator)
- NCT03697512 (Principal Investigator)
- NCT04446962 (Principal Investigator)
- NCT02649790 (Principal Investigator)
- NCT05790733 (Principal Investigator)
- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
- NCT05181735 (Principal Investigator)
Conditions:- Bone Marrow Biopsy;
- Splenic Marginal Zone Lymphoma;
- Marginal Zone Lymphoma;
- Nodal Marginal Zone Lymphoma;
- Lymphoma, Large B-Cell, Diffuse;
- Central Nervous System Neoplasms, Primary;
- Acute Myeloid Leukemia (AML);
- Metastatic Colorectal Cancer (mCRC);
- Metastatic Castration-Resistant Prostate Cancer (mCRPC);
- Relapsed/Refractory Multiple Myeloma (RRMM);
- Higher-Risk Myelodysplastic Syndrome (HR-MDS);
- Newly Diagnosed Intermediate/High-Risk MDS;
- Chemotherapy Effect;
- Aplasia;
- Chronic Myeloid Leukemia;
- Untreated Myelodysplastic Syndrome;
- Myelodysplastic Syndromes;
- MDS
-
Emmanuelle TavernierSeen in:
- Saint-Priest-en-Jarez, CHU Saint Etienne
- Saint-Priest-en-Jarez, CHU de Saint Etienne
- Saint-Étienne, CHU Saint-Etienne
- Saint-Étienne, CHU de Saint-Etienne
- Saint-Étienne, Hématologie clinique Institut de Cancérologie de la Loire
Trials:- NCT04797780 (Principal Investigator)
- NCT05260528 (Principal Investigator)
- NCT03481868 (Principal Investigator)
- NCT04935684 (Principal Investigator)
- NCT03233074 (Sub-Investigator)
-
Eric SOLARY, MDSeen in:
- Dijon, CHU Dijon
Trials:- NCT00411905 (Sub-Investigator)
Conditions: -
Eric Wattel, MD, PHDSeen in:
- Lyon, Centre Hospitalier Lyon Sud
- Pierre-Bénite, Centre Hospitalier Lyon-Sud
Trials:- NCT03223961 (Principal Investigator)
- NCT03454984 (Principal Investigator)
Conditions: -
ESCOFFRE-BARBE, MDSeen in:
- Rennes, Chu Pontchaillou
Trials:- NCT00443339 (Principal Investigator)
Conditions: -
Etienne Daguindau, MDSeen in:
- Besançon, Hématologie clinique CHU Besançon
Trials:- NCT04935684 (Principal Investigator)
-
Etienne PAUBELLESeen in:
- Amiens, Amiens CHU
- Amiens, CHU Amiens-Picardie
Trials:- NCT03643042 (Principal Investigator)
- NCT05181735 (Principal Investigator)
Conditions: -
Faezeh Izadifar LegrandSeen in:
- Bouches Du Rhône, Marseille, Institut Paoli Calmettes
Trials:- NCT03232268 (Principal Investigator)
Conditions: -
FOUILLARD, MDSeen in:
- Paris, Hopital Saint Antoine
Trials:- NCT00443339 (Sub-Investigator)
Conditions: -
Franciane PAUL, MDSeen in:
- Montpellier, CHU De Montpellier - Hopital Saint Eloi
- Montpellier, Chu Saint Eloi
Trials:- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Franck DELPRETTISeen in:
- Vichy, CH Jacques Lacarin
Trials:- NCT03800095 (Sub-Investigator)
-
François DREYFUS, ProfesorSeen in:
- Paris, Hôpital Cochin
Trials:- NCT00411905 (Principal Investigator)
Conditions: -
Frédéric PENE, MD, PhDSeen in:
- Villejuif, Gustave Roussy Institut
Trials:- NCT04953312 (Sub-Investigator)
-
Frederic PEYRADE, PHSeen in:
- Nice, Centre Antoine Lacassagne
Trials:- NCT01210274 (Sub-Investigator)
-
Fressia Honeyman, PhDSeen in:
- Saint-Étienne, CHU de Saint-Etienne
Trials:- NCT03233074 (Sub-Investigator)
-
G. Roth-GuepinSeen in:
- Vandœuvre-lès-Nancy, FR-Vandoeuvre Les Nancy-CHRUNANCY
Trials:- NCT04027309 (Principal Investigator)
-
Gabriel ETIENNE, MDSeen in:
- Bordeaux, Institut Bergonié
Trials:- NCT00411905 (Sub-Investigator)
Conditions: -
Gaëlle FossardSeen in:
- Lyon, Ch Lyon Sud
- Pierre-Bénite, CHU Lyon Sud
- Pierre-Bénite, Centre Hospitalier Lyon Sud
- Pierre-Bénite, Centre Hospitalier Lyon-Sud
Trials:- NCT04797780 (Principal Investigator)
- NCT05181735 (Principal Investigator)
- NCT05226455 (Principal Investigator)
- NCT05782127 (Principal Investigator)
Conditions:
Clinical Trials on Myelodysplastic Syndromes
-
National Cancer Institute (NCI)CompletedPreviously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic SyndromesUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedPreviously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic SyndromesUnited States
-
GCP-Service International West GmbHSaint-Louis Hospital, Paris, France; University of Florence; Medical University... and other collaboratorsNot yet recruitingLow Risk Myelodysplastic SyndromesSpain, Poland, Italy, Germany, France
-
Dana-Farber Cancer InstituteCompletedMyelodysplastic Syndromes (MDS)United States
-
SCRI Development Innovations, LLCNovartis PharmaceuticalsTerminated
-
PersImmune, IncUniversity of California, San DiegoUnknown
-
M.D. Anderson Cancer CenterNot yet recruitingMyeloproliferative Neoplasm | Myelodysplastic Neoplasm | Pathway Mutant Myelodysplastic SyndromesUnited States
-
TJ Biopharma Co., Ltd.Recruiting
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI)RecruitingMyelodysplastic Syndromes (MDS)United States, Israel
-
AbbVieCelgene; Genentech, Inc.CompletedMyelodysplastic Syndromes (MDS)United States, Australia, Germany